Company
Headquarters: Jeddah, Saudi Arabia
SR7.90 Billion
SAR as of July 1, 2024
US$2.10 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Middle East and North Africa. The company operates multi-specialty tertiary level hospitals, which comprise Saudi German HospitalÂJeddah with 218 beds; Saudi German Hospital-Aseer with 400 beds; Saudi German Hospital-Riyadh with 300 beds; Saudi German Hospital-Madinah with 300 beds; and Saudi German Hospital-Hail with 150 beds. Its multi-specialty tertiary care hospitals also include Saudi German Hospital-Dammam with 150 to 300 beds; Saudi German Hospital-Sanaa with 300 beds; Saudi German HospitalÂDubai with 300 beds; Saudi German HospitalÂSharjah with 50 beds; Saudi German HospitalÂAjman with 100-200 beds; and Saudi German Hospital-Cairo with 332 beds. The company was founded in 1988 and is based in Jeddah, the Kingdom of Saudi Arabia.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Middle East Healthcare Company has the following listings and related stock indices.
Stock: Tadawul: 4009 wb_incandescent